The Latin America, Middle East and Africa Cell Therapy Market would witness market growth of 31.8% CAGR during the forecast period (2020-2026). Direct cell reprogramming has gained massive attention as a unique therapeutic strategy. This is due to the superior efficacy and security.
A privately-owned company, Fortuna Fix is making efforts to become the first-ever company to begin clinical use of neural stem cells of patients, which will be generated by direct reprogramming for substitution of lost neuronal tissue in case of neurotrauma or neurodegeneration. These ongoing activities would contribute to market development.
With considerable efforts and regulations being deployed to contain the spread of the COVID-19 crisis, the cell therapy market has been influenced to some degree. Improvement in ongoing research is a major concern, as the majority of universities across the world have reduced their enrollment process for clinical trials for all other research activities.
The arrival of modern technologies has encouraged the development of advanced cellular therapies growth. Companies are using the latest technologies with an aim to increase their product offerings and set-up out-licensing or co-development agreements with other bodies to encourage their product development programs.
The Brazil market dominated the LAMEA Non-Stem Cell Market by Country 2019, and would continue to be a dominant market till 2026. The Argentina market would witness a CAGR of 34.6% during (2020 - 2026). Additionally, The UAE market is exhibiting a CAGR of 33.6% during (2020 - 2026).
The Autologous market dominated the Saudi Arabia Cell Therapy Market by Therapy Type 2019, thereby, achieving a market value of $145.2 million by 2026. Additionally, The Allogeneic market is expected to witness highest CAGR of 35% during (2020 - 2026).
Based on Therapy Type, the market is segmented into Autologous and Allogeneic. Based on Therapeutic Area, the market is segmented into Malignancies, Autoimmune Disorders, Musculoskeletal Disorders, Dermatology and Others. Based on End User, the market is segmented into Academic & Research Institutes and Hospitals & Clinics. Based on Cell Type, the market is segmented into Stem Cell, Umbilical Cord-Derived, Adipose-Derived Stem Cell, Non-Stem Cell, Bone Marrow, Blood and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: Cell Therapy Market in LAMEA is expected to register a CAGR of 31.8% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fujifilm Holdings Corporation, Smith & Nephew PLC, Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Medipost Co., Ltd., Stemedica Cell Technologies, Inc., NuVasive, Inc., Avantor, Inc., Vericel Corporation, and Pharmicell Co., Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Therapy Type
By Therapeutic Area
- Malignancies
- Autoimmune Disorders
- Musculoskeletal Disorders
- Dermatology
- Others
By End User
- Academic & Research Institutes
- Hospitals & Clinics
By Cell Type
- Stem Cell
- Umbilical Cord-Derived
- Adipose-Derived Stem Cell
- Non-Stem Cell
- Bone Marrow
- Blood
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Fujifilm Holdings Corporation
- Smith & Nephew PLC
- Kolon TissueGene, Inc.
- JCR Pharmaceuticals Co., Ltd.
- Medipost Co., Ltd.
- Stemedica Cell Technologies, Inc.
- NuVasive, Inc.
- Avantor, Inc.
- Vericel Corporation
- Pharmicell Co., Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Cell Therapy Market, by Therapy Type
1.4.2 LAMEA Cell Therapy Market, by Therapeutic Area
1.4.3 LAMEA Cell Therapy Market, by End User
1.4.4 LAMEA Cell Therapy Market, by Cell Type
1.4.5 LAMEA Cell Therapy Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Approvals & Trials
3.2.5 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
Chapter 4. LAMEA Cell Therapy Market by Therapy Type
4.1 LAMEA Autologous Market by Country
4.2 LAMEA Allogeneic Market by Country
Chapter 5. LAMEA Cell Therapy Market by Therapeutic Area
5.1 LAMEA Malignancies Market by Country
5.2 LAMEA Autoimmune Disorders Market by Country
5.3 LAMEA Musculoskeletal Disorders Market by Country
5.4 LAMEA Dermatology Market by Country
5.5 LAMEA Other Therapeutic Area Market by Country
Chapter 6. LAMEA Cell Therapy Market by End User
6.1 LAMEA Academic & Research Institutes Market by Country
6.2 LAMEA Hospitals & Clinics Market by Country
Chapter 7. LAMEA Cell Therapy Market by Cell Type
7.1 LAMEA Stem Cell Market by Country
7.2 LAMEA Umbilical Cord-Derived Cell Market by Country
7.3 LAMEA Adipose-Derived Stem Cell Market by Country
7.4 LAMEA Non-Stem Cell Market by Country
7.5 LAMEA Bone Marrow Cell Market by Country
7.6 LAMEA Blood Cell Market by Country
7.7 LAMEA Others Cell Market by Country
Chapter 8. LAMEA Cell Therapy Market by Country
8.1 Brazil Cell Therapy Market
8.1.1 Brazil Cell Therapy Market by Therapy Type
8.1.2 Brazil Cell Therapy Market by Therapeutic Area
8.1.3 Brazil Cell Therapy Market by End User
8.1.4 Brazil Cell Therapy Market by Cell Type
8.2 Argentina Cell Therapy Market
8.2.1 Argentina Cell Therapy Market by Therapy Type
8.2.2 Argentina Cell Therapy Market by Therapeutic Area
8.2.3 Argentina Cell Therapy Market by End User
8.2.4 Argentina Cell Therapy Market by Cell Type
8.3 UAE Cell Therapy Market
8.3.1 UAE Cell Therapy Market by Therapy Type
8.3.2 UAE Cell Therapy Market by Therapeutic Area
8.3.3 UAE Cell Therapy Market by End User
8.3.4 UAE Cell Therapy Market by Cell Type
8.4 Saudi Arabia Cell Therapy Market
8.4.1 Saudi Arabia Cell Therapy Market by Therapy Type
8.4.2 Saudi Arabia Cell Therapy Market by Therapeutic Area
8.4.3 Saudi Arabia Cell Therapy Market by End User
8.4.4 Saudi Arabia Cell Therapy Market by Cell Type
8.5 South Africa Cell Therapy Market
8.5.1 South Africa Cell Therapy Market by Therapy Type
8.5.2 South Africa Cell Therapy Market by Therapeutic Area
8.5.3 South Africa Cell Therapy Market by End User
8.5.4 South Africa Cell Therapy Market by Cell Type
8.6 Nigeria Cell Therapy Market
8.6.1 Nigeria Cell Therapy Market by Therapy Type
8.6.2 Nigeria Cell Therapy Market by Therapeutic Area
8.6.3 Nigeria Cell Therapy Market by End User
8.6.4 Nigeria Cell Therapy Market by Cell Type
8.7 Rest of LAMEA Cell Therapy Market
8.7.1 Rest of LAMEA Cell Therapy Market by Therapy Type
8.7.2 Rest of LAMEA Cell Therapy Market by Therapeutic Area
8.7.3 Rest of LAMEA Cell Therapy Market by End User
8.7.4 Rest of LAMEA Cell Therapy Market by Cell Type
Chapter 9. Company Profiles
9.1 Fujifilm Holdings Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Geographical Expansions:
9.2 Smith & Nephew PLC
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.5.2 Acquisition and Mergers:
9.3 Kolon TissueGene, Inc.
9.3.1 Company Overview
9.3.2 Recent strategies and developments:
9.3.2.1 Approvals & Trials:
9.4 JCR Pharmaceuticals Co., Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Research & Development Expense
9.4.4 Recent strategies and developments:
9.4.4.1 Partnerships, Collaborations, and Agreements:
9.4.4.2 Acquisition and Mergers:
9.4.4.3 Approvals & Trials:
9.5 Medipost Co., Ltd.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Recent strategies and developments:
9.5.3.1 Partnerships, Collaborations, and Agreements:
9.5.3.2 Approvals & Trials:
9.6 Stemedica Cell Technologies, Inc.
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Approvals & Trials:
9.7 NuVasive, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.8 Avantor, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Product Launches and Product Expansions:
9.8.4.2 Geographical Expansions:
9.9 Vericel Corporation
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Research & Development Expense
9.9.4 Recent strategies and developments:
9.9.4.1 Partnerships, Collaborations, and Agreements:
9.9.4.2 Product Launches and Product Expansions:
9.10. Pharmicell Co., Ltd.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Research & Development Expense
9.10.4 Recent strategies and developments:
9.10.4.1 Partnerships, Collaborations, and Agreements:
TABLE 1 LAMEA Cell Therapy Market, 2016 - 2019, USD Million
TABLE 2 LAMEA Cell Therapy Market, 2020 - 2026, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Cell Therapy Market
TABLE 4 Product Launches And Product Expansions– Cell Therapy Market
TABLE 5 Geographical Expansions– Cell Therapy Market
TABLE 6 Approvals & Trials– Cell Therapy Market
TABLE 7 Acquisition and Mergers– Cell Therapy Market
TABLE 8 LAMEA Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 9 LAMEA Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 10 LAMEA Autologous Market by Country, 2016 - 2019, USD Million
TABLE 11 LAMEA Autologous Market by Country, 2020 - 2026, USD Million
TABLE 12 LAMEA Allogeneic Market by Country, 2016 - 2019, USD Million
TABLE 13 LAMEA Allogeneic Market by Country, 2020 - 2026, USD Million
TABLE 14 LAMEA Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 15 LAMEA Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 16 LAMEA Malignancies Market by Country, 2016 - 2019, USD Million
TABLE 17 LAMEA Malignancies Market by Country, 2020 - 2026, USD Million
TABLE 18 LAMEA Autoimmune Disorders Market by Country, 2016 - 2019, USD Million
TABLE 19 LAMEA Autoimmune Disorders Market by Country, 2020 - 2026, USD Million
TABLE 20 LAMEA Musculoskeletal Disorders Market by Country, 2016 - 2019, USD Million
TABLE 21 LAMEA Musculoskeletal Disorders Market by Country, 2020 - 2026, USD Million
TABLE 22 LAMEA Dermatology Market by Country, 2016 - 2019, USD Million
TABLE 23 LAMEA Dermatology Market by Country, 2020 - 2026, USD Million
TABLE 24 LAMEA Other Therapeutic Area Market by Country, 2016 - 2019, USD Million
TABLE 25 LAMEA Other Therapeutic Area Market by Country, 2020 - 2026, USD Million
TABLE 26 LAMEA Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 27 LAMEA Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 28 LAMEA Academic & Research Institutes Market by Country, 2016 - 2019, USD Million
TABLE 29 LAMEA Academic & Research Institutes Market by Country, 2020 - 2026, USD Million
TABLE 30 LAMEA Hospitals & Clinics Market by Country, 2016 - 2019, USD Million
TABLE 31 LAMEA Hospitals & Clinics Market by Country, 2020 - 2026, USD Million
TABLE 32 LAMEA Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 33 LAMEA Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 34 LAMEA Stem Cell Market by Country, 2016 - 2019, USD Million
TABLE 35 LAMEA Stem Cell Market by Country, 2020 - 2026, USD Million
TABLE 36 LAMEA Umbilical Cord-Derived Cell Market by Country, 2016 - 2019, USD Million
TABLE 37 LAMEA Umbilical Cord-Derived Cell Market by Country, 2020 - 2026, USD Million
TABLE 38 LAMEA Adipose-Derived Stem Cell Market by Country, 2016 - 2019, USD Million
TABLE 39 LAMEA Adipose-Derived Stem Cell Market by Country, 2020 - 2026, USD Million
TABLE 40 LAMEA Non-Stem Cell Market by Country, 2016 - 2019, USD Million
TABLE 41 LAMEA Non-Stem Cell Market by Country, 2020 - 2026, USD Million
TABLE 42 LAMEA Bone Marrow Cell Market by Country, 2016 - 2019, USD Million
TABLE 43 LAMEA Bone Marrow Cell Market by Country, 2020 - 2026, USD Million
TABLE 44 LAMEA Blood Cell Market by Country, 2016 - 2019, USD Million
TABLE 45 LAMEA Blood Cell Market by Country, 2020 - 2026, USD Million
TABLE 46 LAMEA Others Cell Market by Country, 2016 - 2019, USD Million
TABLE 47 LAMEA Others Cell Market by Country, 2020 - 2026, USD Million
TABLE 48 LAMEA Cell Therapy Market by Country, 2016 - 2019, USD Million
TABLE 49 LAMEA Cell Therapy Market by Country, 2020 - 2026, USD Million
TABLE 50 Brazil Cell Therapy Market, 2016 - 2019, USD Million
TABLE 51 Brazil Cell Therapy Market, 2020 - 2026, USD Million
TABLE 52 Brazil Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 53 Brazil Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 54 Brazil Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 55 Brazil Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 56 Brazil Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 57 Brazil Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 58 Brazil Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 59 Brazil Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 60 Argentina Cell Therapy Market, 2016 - 2019, USD Million
TABLE 61 Argentina Cell Therapy Market, 2020 - 2026, USD Million
TABLE 62 Argentina Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 63 Argentina Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 64 Argentina Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 65 Argentina Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 66 Argentina Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 67 Argentina Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 68 Argentina Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 69 Argentina Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 70 UAE Cell Therapy Market, 2016 - 2019, USD Million
TABLE 71 UAE Cell Therapy Market, 2020 - 2026, USD Million
TABLE 72 UAE Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 73 UAE Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 74 UAE Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 75 UAE Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 76 UAE Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 77 UAE Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 78 UAE Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 79 UAE Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 80 Saudi Arabia Cell Therapy Market, 2016 - 2019, USD Million
TABLE 81 Saudi Arabia Cell Therapy Market, 2020 - 2026, USD Million
TABLE 82 Saudi Arabia Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 83 Saudi Arabia Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 84 Saudi Arabia Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 85 Saudi Arabia Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 86 Saudi Arabia Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 87 Saudi Arabia Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 88 Saudi Arabia Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 89 Saudi Arabia Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 90 South Africa Cell Therapy Market, 2016 - 2019, USD Million
TABLE 91 South Africa Cell Therapy Market, 2020 - 2026, USD Million
TABLE 92 South Africa Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 93 South Africa Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 94 South Africa Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 95 South Africa Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 96 South Africa Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 97 South Africa Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 98 South Africa Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 99 South Africa Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 100 Nigeria Cell Therapy Market, 2016 - 2019, USD Million
TABLE 101 Nigeria Cell Therapy Market, 2020 - 2026, USD Million
TABLE 102 Nigeria Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 103 Nigeria Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 104 Nigeria Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 105 Nigeria Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 106 Nigeria Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 107 Nigeria Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 108 Nigeria Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 109 Nigeria Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 110 Rest of LAMEA Cell Therapy Market, 2016 - 2019, USD Million
TABLE 111 Rest of LAMEA Cell Therapy Market, 2020 - 2026, USD Million
TABLE 112 Rest of LAMEA Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
TABLE 113 Rest of LAMEA Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
TABLE 114 Rest of LAMEA Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
TABLE 115 Rest of LAMEA Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
TABLE 116 Rest of LAMEA Cell Therapy Market by End User, 2016 - 2019, USD Million
TABLE 117 Rest of LAMEA Cell Therapy Market by End User, 2020 - 2026, USD Million
TABLE 118 Rest of LAMEA Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
TABLE 119 Rest of LAMEA Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
TABLE 120 Key Information – Fujifilm Holdings Corporation
TABLE 121 key Information – Smith & Nephew PLC
TABLE 122 key information – Kolon TissueGene, Inc.
TABLE 123 Key Information – JCR Pharmaceuticals Co., Ltd.
TABLE 124 Key Information – Medipost Co., Ltd.
TABLE 125 key Information – Stemedica Cell Technologies, Inc.
TABLE 126 Key Information – NuVasive, Inc.
TABLE 127 key information – Avantor, Inc.
TABLE 128 Key Information – Vericel Corporation
TABLE 129 Key Information – Pharmicell Co., Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Recent strategies and developments: Fujifilm Holdings Corporation
FIG 5 Recent strategies and developments: Smith & Nephew PLC
FIG 6 Recent strategies and developments: JCR Pharmaceuticals Co., Ltd.
FIG 7 Recent strategies and developments: Avantor, Inc.
FIG 8 Recent strategies and developments: Vericel Corporation